Grape downy mildew in India I. Foliar, floral and fruit infections

The incidence and intensity of downy mildew on "Anab-e-Shahi" grapevine were recorded on leaves of six ages as indicated by colours. Red and green with orange leaves did not show symptoms of the disease. The rate of disease development was highest in agathia-green and viridian-green leaves. The time taken for reaching grade 3 from grade 2 was shorter than the time taken for development to grade 2 from grade 1. The incubation periods were 18 and 14 days in red and green with orange leaves, respectively. But in older leaves it was only 10 days. In leaves of all colours the stomatal pore was broader than the width of the germ tube of the pathogen. Upon artificial inoculation inflorescences as weil as clusters with mustard seed-sized (2.00 mm) and pea-sized (6.5 mm) berries became infected whereas older bunches with neem-sized (12.5 mm) and mature berries were not infected. Complete shed of infected flowers and mustard seed-sized berries and a drop of 53.1 per cent of pea-sized berries were noticed.Der falsche Rebenmehltau in IndienI. Befall von Blättern, Blüten und BeerenBei der Rebensorte Anab-e-Shahi wurden Auftreten und Intensität des Befalls durch Plasmopara viticola an sechs durch ihre Färbung gekennzeichneten Blattstadien verfolgt. Rote und grün-orange gefärbte Blätter zeigten keine Krankheitssymptome. Agathia- und chromgrüne Blätter erkrankten am häufigsten. Der Übergang von Parasitierungsgrad 1 nach 2 dauerte länger als von 2 nach 3 (1 = bis zu 25%, 2 = 26-50%, 3 = über 50% der Blattfläche von Myzel bedeckt). Bei den roten und grün-orange gefärbten Blättern betrug die Inkubationszeit 18 bzw. 14 Tage, bei älteren Blättern dagegen nur noch 10 Tage. Die Weite der Spaltöffnungen war bei allen Blattstadien größer als der Durchmesser des Sporenkeimschlauches. Nach künstlicher Infektion wurden sowohl Infloreszenzen wie Trauben mit 2,0 mm und 6,5 mm großen Beeren befallen, während ältere Trauben mit 12,5 mm großen sowie mit reifen Beeren nicht erkrankten. Infizierte Blüten verrieselten vollständig; bei einer Größe von 2,0 mm fielen 53,1% der Beeren ab

Insecticidal activity and changes in midgut histology of the generalist herbivore, Spodoptera litura F. (Lepidoptera: Noctuidae) in response to seed extract of Annona squamosa Linn.

The tobacco caterpillar, Spodoptera litura F., is one of the most devastating, cosmopolitan polyphagous pests affecting major crops that significantly impact agricultural productivity. The present study aimed to evaluate the toxicological effect of seed extract of the medicinal plant, Annona squamosa L. and the histological effect on the midgut of Spodoptera litura F., under laboratory conditions. The crude methanolic extract of A. squamosa seed was tested against the third instar larvae of S. litura at five different concentrations viz., 0.5%, 1.0%, 1.5%, 2.0% and 2.5 % by leaf dip bioassay method. The seed extract exhibited larval mortality of 96.67%, 83.37 %,70%, 53.33% and 40 % at the concentrations 2.5 %, 2.0%, 1.5%, 1.0% and 0.5%, respectively.The results indicated that the response of larval mortality to the seed extract was dose-dependent. The dose of 0.5% showed the lowest mortality (40.00%), while the dose of 2.5 % showed maximum larval mortality (96.67%). Hence they were subjected to histological analysis. The anatomical sectioning of S. litura larval midgut treated with 0.5% concentration showed disruption in the peritrophic membrane and striated border of epithelial cells. The midgut of larvae treated with 2.5 % concentration showed an irregular epithelium and high vacuolization in the cytoplasmic cells. The results indicated that methanol extract of A. squamosa seed extract has the ability to cause changes in the midgut region, thereby affecting the digestion and nutrient absorption of S. litura larvae, which will lead to a debilitating effect on the development of larvae. Based on the present study A. squamosa seed extract will be a potential biopesticide for managing S. litura

Novel gene function revealed by mouse mutagenesis screens for models of age-related disease

Determining the genetic bases of age-related disease remains a major challenge requiring a spectrum of approaches from human and clinical genetics to the utilization of model organism studies. Here we report a large-scale genetic screen in mice employing a phenotype-driven discovery platform to identify mutations resulting in age-related disease, both late-onset and progressive. We have utilized N-ethyl-N-nitrosourea mutagenesis to generate pedigrees of mutagenized mice that were subject to recurrent screens for mutant phenotypes as the mice aged. In total, we identify 105 distinct mutant lines from 157 pedigrees analysed, out of which 27 are late-onset phenotypes across a range of physiological systems. Using whole-genome sequencing we uncover the underlying genes for 44 of these mutant phenotypes, including 12 late-onset phenotypes. These genes reveal a number of novel pathways involved with age-related disease. We illustrate our findings by the recovery and characterization of a novel mouse model of age-related hearing loss

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Intraperitoneal drain placement and outcomes after elective colorectal surgery: international matched, prospective, cohort study

Despite current guidelines, intraperitoneal drain placement after elective colorectal surgery remains widespread. Drains were not associated with earlier detection of intraperitoneal collections, but were associated with prolonged hospital stay and increased risk of surgical-site infections.Background Many surgeons routinely place intraperitoneal drains after elective colorectal surgery. However, enhanced recovery after surgery guidelines recommend against their routine use owing to a lack of clear clinical benefit. This study aimed to describe international variation in intraperitoneal drain placement and the safety of this practice. Methods COMPASS (COMPlicAted intra-abdominal collectionS after colorectal Surgery) was a prospective, international, cohort study which enrolled consecutive adults undergoing elective colorectal surgery (February to March 2020). The primary outcome was the rate of intraperitoneal drain placement. Secondary outcomes included: rate and time to diagnosis of postoperative intraperitoneal collections; rate of surgical site infections (SSIs); time to discharge; and 30-day major postoperative complications (Clavien-Dindo grade at least III). After propensity score matching, multivariable logistic regression and Cox proportional hazards regression were used to estimate the independent association of the secondary outcomes with drain placement. Results Overall, 1805 patients from 22 countries were included (798 women, 44.2 per cent; median age 67.0 years). The drain insertion rate was 51.9 per cent (937 patients). After matching, drains were not associated with reduced rates (odds ratio (OR) 1.33, 95 per cent c.i. 0.79 to 2.23; P = 0.287) or earlier detection (hazard ratio (HR) 0.87, 0.33 to 2.31; P = 0.780) of collections. Although not associated with worse major postoperative complications (OR 1.09, 0.68 to 1.75; P = 0.709), drains were associated with delayed hospital discharge (HR 0.58, 0.52 to 0.66; P < 0.001) and an increased risk of SSIs (OR 2.47, 1.50 to 4.05; P < 0.001). Conclusion Intraperitoneal drain placement after elective colorectal surgery is not associated with earlier detection of postoperative collections, but prolongs hospital stay and increases SSI risk

The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4 weeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4 weeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, P = 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, P < 0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, P = 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, P = 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease

Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic

Studies on the physiology of chilli plants (Capsicum annuum L.) affected by potato virus Y. I. Effect on metabolism of carbohydrates, organic acids, phenolics, and respiration

This article does not have an abstract